H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 10.7% of adults in Wilmington have diagnosed diabetes — 1.3 points below the U.S. 12% figure. Census population 115,451. North Carolina Medicare wound biologics: Palmetto GBA (JM). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Wilmington clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Wilmington storefront.
Biologic Solutions for Chronic Wounds in Wilmington, NC for clinics & physicians. Biologic solutions for c… Compliance support & pricing — contact Hawk Medical.
Adult obesity in Wilmington is 31.9% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. CDC PLACES (2023, crude) estimates 10.7% of adults in Wilmington have diagnosed diabetes — 1.3 points below the U.S. 12% figure. North Carolina includes CDC Diabetes Belt counties, so DFU planning belongs in the annual budget. Hawk Medical is the distributor for biologic solutions chronic wounds, not a walk-in clinic.
National Biologic Solutions for Chronic Wounds notes (how the product actually works)America’s Health Rankings (BRFSS 2024) only publishes state diabetes as a range nationally (Colorado 8.4% to West Virginia 18.4%). For Wilmington we use CDC PLACES instead of interpolating a fake city rate from that range. CDC PLACES (2023, crude) estimates 10.7% of adults in Wilmington have diagnosed diabetes — 1.3 points below the U.S. 12% figure.
If you already buy biologic solutions chronic wounds elsewhere, use this page as a check: homologous-use language, current Palmetto GBA article IDs, and PLACES 10.7% diabetes as the epidemiologic floor. If that is how you already practice, the catalog will fit.
CDC PLACES (2023, crude prevalence) estimates 10.7% of adults — 1.3 points below the U.S. 12% figure. Obesity is 31.9%; arthritis is 26%. That is place-level BRFSS modeling, not a clinic census and not a Wilmington trial.
It is the Census city-proper count — useful as scale for a city under 250k. It is not a count of orthopedic groups, wound centers, or competitors. Underwrite the program against your referral sources, not against the skyline.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including North Carolina.
Joe Bradley, Founder & CEO of Hawk Medical LLC, is an active clinical practice owner. These programmatic pages are distribution resources for providers, reviewed against the same HCT/P and wound-care portfolio used in that practice. They are not patient treatment advice.
If you operate in North Carolina and another MAC state, say it on the first call. JM will not port 1:1. We would rather split utilization than watch a sister clinic copy Wilmington tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Wilmington, NC.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Wilmington is JM geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Wilmington — 1.3 points below the U.S. 12% figure. Planning input, not an outcomes claim.
North Carolina Part B wound biologics follow this contractor (siblings: SC, VA, WV). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Wilmington. Useful for joint-program math; still needs a diagnosis and privileging.
No Wilmington storefront. Joe Bradley is an active practice owner. biologic solutions chronic wounds stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.